SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 693.35-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Miljenko Zuanic1/10/2019 12:20:39 PM
   of 3557
 
I am still ????(and confused) about REGN rising $1B, from nowhere. Like they have PURE $$$balance and future CF (which is not a case). So, what is up?
Are they interested in acquiring bios (<1B), or large 50:50 partnership (where they will be one supplying $$$$)?

What about ADVM? ( cell.com )
At what possible price????
Last public offer was at $6.75 (2-2018)!
Is RGNX with RGX-314 real threat to Eylea and how can REGN contra-act??/

Anyone with any idea what/where may be REGN interest???
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext